Brazil Cancer Diagnostics Market Size & Outlook, 2023-2030
Brazil cancer diagnostics market, 2018-2030 (US$M)
Related Markets
Brazil cancer diagnostics market highlights
- The Brazil cancer diagnostics market generated a revenue of USD 3,704.9 million in 2023 and is expected to reach USD 5,644.8 million by 2030.
- The Brazil market is expected to grow at a CAGR of 6.2% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Cancer diagnostics market data book summary
| Market revenue in 2023 | USD 3,704.9 million |
| Market revenue in 2030 | USD 5,644.8 million |
| Growth rate | 6.2% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Instruments, Consumables |
| Key market players worldwide | Abbott Laboratories, Roche Holding AG, GE HealthCare Technologies Inc Common Stock, Qiagen NV, Becton Dickinson & Co, Koninklijke Philips NV, Siemens Healthineers AG ADR, Hologic Inc, Thermo Fisher Scientific Inc, Illumina Inc |
Other key industry trends
- In terms of revenue, Brazil accounted for 3.4% of the global cancer diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 3,107.1 million by 2030.
Consumables was the largest segment with a revenue share of 59.99% in 2023. Horizon Databook has segmented the Brazil cancer diagnostics market based on services, instruments, consumables covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil has the largest population in Latin America. Thus, cancer incidence in the country is high, which has led to increased usage of various novel cancer screening tools such as liquid biopsy and gene panel testing.
However, it may take some time for liquid biopsy to be used widely in the country owing to the expensive testing procedure and very limited availability of skilled professionals. Many professionals in Brazil consider solid tumor biopsy the gold standard, as it offers a deep analysis of cancer mutation.
However, in the past few years, Brazil has witnessed high growth in the adoption of liquid biopsy techniques owing to increasing collaborations between key market players and various initiatives being undertaken by several organizations for cancer care.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Diagnostics Market Scope
Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil cancer diagnostics market size, by product, 2018-2030 (US$M)
Brazil Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
